IMO is pleased to announce that Dale Sanders has joined the organization as Chief Strategy Officer. This is another milestone in the company’s move from legacy products in terminology to developing new technologies to improve data quality and insights.
Sanders has three decades of experience in health IT and a 15-year history with IMO, first as a client, while he was CIO at Northwestern University Feinberg School of Medicine where he immediately saw the value of IMO’s terminology products to improve EHR workflow efficiencies. Most recently, Sanders served as CTO at Health Catalyst, where he was in a unique position to observe the challenges with data quality at the national level – an issue brought into sharper focus by the COVID-19 pandemic.
Built on its foundation in clinical terminology, IMO delivers products that enable accurate documentation, precise population cohorting, optimized reimbursements, robust analytics, and improved care decisions to optimize patient outcomes. While the company’s products have historically benefited providers, new offerings that enhance data quality and integrity are poised to make a powerful impact in other areas of the industry like value-based care and life sciences.